{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:17:18Z","timestamp":1787977038823,"version":"build-2784847793"},"reference-count":12,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,8,25]]},"DOI":"10.1248\/bpb.b26-00201","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:14:01Z","timestamp":1787609641000},"page":"1285-1290","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Adjusted Creatinine Clearance on Carboplatin Dosing in Endometrial Cancer: A Retrospective Study"],"prefix":"10.1248","volume":"49","author":[{"given":"Kentaro","family":"Katayama","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710\u20138522, Japan"},{"name":"Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138530, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makio","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Clinical Support, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710\u20138522, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700\u20138530, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Calvert AH, Newell DR, Gumbrell LA, O\u2019Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J. Clin. Oncol.<\/i>, 7<\/b>, 1748\u20131756 (1989).","DOI":"10.1200\/JCO.1989.7.11.1748"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J. Clin. Oncol.<\/i>, 10<\/b>, 520\u2013528 (1992).","DOI":"10.1200\/JCO.1992.10.4.520"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Adjustment of creatinine clearance improves accuracy of Calvert\u2019s formula for carboplatin dosing. Br. J. Cancer<\/i>, 76<\/b>, 1067\u20131071 (1997).","DOI":"10.1038\/bjc.1997.509"},{"key":"4","unstructured":"4) Ando Y, Shimokata T, Yasuda Y, Hasegawa Y. Carboplatin dosing for adult Japanese patients. Nagoya J. Med. Sci.<\/i>, 76<\/b>, 1\u20139 (2014)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hatta T, Hase T, Hara T, Kimura T, Kojima E, Abe T, Horio Y, Goto Y, Ozawa N, Yogo N, Shibata H, Shimokata T, Oguri T, Yamamoto M, Yanagisawa K, Ando M, Ando Y, Kondo M, Ishii M, Hasegawa Y. Adjustment of creatinine clearance for carboplatin dosing in Calvert\u2019s formula and clinical efficacy for lung cancer. Cancer Med.<\/i>, 12<\/b>, 15955\u201315969 (2023).","DOI":"10.1002\/cam4.6235"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I. Difference of carboplatin clearance estimated by the Cockcroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula. Gynecol. Oncol.<\/i>, 99<\/b>, 327\u2013333 (2005).","DOI":"10.1016\/j.ygyno.2005.06.003"},{"key":"7","unstructured":"7) Ando M, Minami H, Ando Y, Saka H, Sakai S, Yamamoto M, Sasaki Y, Shimokata K, Hasegawa Y. Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level. Clin. Cancer Res.<\/i>, 6<\/b>, 4733\u20134738 (2000)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) ten Bokkel Huinink WW, van Warmerdam LJ, Helmerhorst TJ, Schaefers MC, Beijnen JH, Rodenhuis S. Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer. Ann. Oncol.<\/i>, 8<\/b>, 351\u2013354 (1997).","DOI":"10.1023\/A:1008219618331"},{"key":"9","unstructured":"9) van Warmerdam LJ, Huizing MT, Giaccone G, Postmus PE, ten Bokkel Huinink WW, van Zandwijk N, Koolen MG, Helmerhorst TJ, van der Vijgh WJ, Veenhof CH, Beijnen JH. Clinical pharmacology of carboplatin administered in combination with paclitaxel. Semin. Oncol.<\/i>, 24<\/b> (1 Suppl. 2), S2-97\u2013S2-104 (1997)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Belani CP, Kearns CM, Zuhowski EG, Erkmen K, Hiponia D, Zacharski D, Engstrom C, Ramanathan RK, Capozzoli MJ, Aisner J, Egorin MJ. Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer. J. Clin. Oncol.<\/i>, 17<\/b>, 676\u2013684 (1999).","DOI":"10.1200\/JCO.1999.17.2.676"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Pertusini E, Ratajczak J, Majka M, Vaughn D, Ratajczak MZ, Gewirtz AM. Investigating the platelet-sparing mechanism of paclitaxel\/carboplatin combination chemotherapy. Blood<\/i>, 97<\/b>, 638\u2013644 (2001).","DOI":"10.1182\/blood.V97.3.638"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nelson WK, Formica RN Jr, Cooper DL, Schwartz PE, Rutherford TJ. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers. J. Oncol. Pharm. Pract.<\/i>, 18<\/b>, 323\u2013332 (2012).","DOI":"10.1177\/1078155211435714"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:28:16Z","timestamp":1787974096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00201","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"b26-00201"}}